Systemic Mastocytosis: Clinical Trials

1 trial for Systemic Mastocytosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Systemic Mastocytosis: new trials by email Literature Review of Systemic Mastocytosis trials Research Report on Systemic Mastocytosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imatinib in KIT-negative Systemic Mastocytosis
Imatinib Mesylate - Systemic Mastocytosis
Phase 4CompletedHospital Virgen de la Salud102011-01-012016-08-29

Narrower conditions

Mast Cell Activation Disorders (1)  ·  Mastocytosis (1)  ·  Mastocytosis, Systemic (1)

Broader conditions

Immune System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Imatinib Mesylate (1)

Sponsors

Hospital Virgen de la Salud (1)

Countries

Spain (1)

Top investigators

Luis Escribano, MD, PhD (1)

Results publications

PMID 15070706, PMID 18567837